Amoéba, an industrial greentech company specialized in the development of natural microbiological solutions, announces that it will present to the agricultural press on 28th October 2025 the positive results of its wine-growing trials in France and Europe.

Very convincing results observed by winegrowers

Under the 120-day emergency marketing authorisation granted by the French authorities in spring 2025^[1] to combat mildew, Amoéba conducted a series of trials with winegrowers in several major French wine-growing regions, including Bordeaux, Burgundy, Provence, and Champagne. The main objectives of this campaign were to demonstrate the effectiveness of “AXPERA”, its innovative biological solution, and to validate its reliability in local programmes and practical conditions.

In all vineyards affected by mildew and powdery mildew, initial feedback from winegrowers has been extremely positive. Several of them are already planning to extend the use of AXPERA to a larger area from 2026 onwards:

“Incorporating AXPERA into my treatment programme has enabled me to reduce copper input to just 1 kg/ha, while achieving better protection against mildew than with my standard programme,” says Victor Sornin, a winegrower in Beaujolais.

For her part, Anne Silberzahn, a winegrower in Côtes de Provence (France), emphasises: “AXPERA has enabled me to halve my copper inputs per hectare without losing any efficiency. This reinforces my belief that I will eventually be able to do without copper altogether.”

Source – Amoeba